Precision in Practice: AI-Enhanced 3D Printing Reshapes Surgical Simulation in Hepatobiliary Care

Updated on: July 02,2025 0

Precision in Practice: AI-Enhanced 3D Printing Reshapes Surgical Simulation in Hepatobiliary Care

Updated on:July 02,2025 0

Physics-Informed Machine Learning: A New Frontier in Personalized Disease Prediction, Prevention, and Management

Updated on: July 02,2025 0

Physics-Informed Machine Learning: A New Frontier in Personalized Disease Prediction, Prevention, and Management

Updated on:July 02,2025 0

Machine Learning for Musculoskeletal Pain Classification: Unlocking Precision in Diagnosis

Updated on: September 01,2025 0

Machine Learning for Musculoskeletal Pain Classification: Unlocking Precision in Diagnosis

Updated on:September 01,2025 0

From Waste to Wellness: Integrating Fractional Fuzzy Logic and Multimodal AI in Smarter Healthcare

Updated on: July 25,2025 0

From Waste to Wellness: Integrating Fractional Fuzzy Logic and Multimodal AI in Smarter Healthcare

Updated on:July 25,2025 0

A Clinically Applicable AI System for Bone Metastasis Detection and Diagnosis Using CT Scans

Updated on: August 25,2025 0

A Clinically Applicable AI System for Bone Metastasis Detection and Diagnosis Using CT Scans

Updated on:August 25,2025 0

Deep Learning in Dermatology: Advancing Skin Disease Diagnosis with AI-Driven Precision

Skin diseases affect over a billion people worldwide, yet accurate diagnosis remains a persistent challenge.

Updated on: September 08,2025 0

Deep Learning in Dermatology: Advancing Skin Disease Diagnosis with AI-Driven Precision

Skin diseases affect over a billion people worldwide, yet accurate diagnosis remains a persistent challenge.

Updated on:September 08,2025 0

Revolutionizing Chronic Ataxia Diagnosis: The Role of Artificial Intelligence

Updated on: September 01,2025 0

Revolutionizing Chronic Ataxia Diagnosis: The Role of Artificial Intelligence

Updated on:September 01,2025 0

Weekly Update of Drug News-4/9/2025

On Aug 21, 2025, Abbvie announced that positive results from study 1 of the Phase 3 UP-AA clinical program evaluating the safety and efficacy of RINVOQ® (Upadacitinib) in adult and adolescent patients with severe alopecia areata (AA) with a mean baseline

Updated on: September 04,2025 0

Weekly Update of Drug News-4/9/2025

On Aug 21, 2025, Abbvie announced that positive results from study 1 of the Phase 3 UP-AA clinical program evaluating the safety and efficacy of RINVOQ® (Upadacitinib) in adult and adolescent patients with severe alopecia areata (AA) with a mean baseline

Updated on:September 04,2025 0

Can AI Catch What Doctors Miss?

Updated on: September 15,2025 0

Can AI Catch What Doctors Miss?

Updated on:September 15,2025 0

AI-Driven Multi-Omics Modeling in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Unlocking the Biological Complexity of a Misunderstood Disease

Updated on: September 08,2025 0

AI-Driven Multi-Omics Modeling in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Unlocking the Biological Complexity of a Misunderstood Disease

Updated on:September 08,2025 0

How AI is Revolutionizing Medicine

Updated on: September 15,2025 0

How AI is Revolutionizing Medicine

Updated on:September 15,2025 0

Is AI transforming the future of healthcare?

Updated on: September 15,2025 0

Is AI transforming the future of healthcare?

Updated on:September 15,2025 0